NSE ScannerChemicals · Chemicals: Specialty · NSE: VINEETLAB · data 2026-10-31
Vineet Laboratories Ltd.
In plain words
Price: 12.8% below its 52-week high of ₹43.5.
Delivery: 71.7% of traded shares were kept for delivery over the last 10 sessions, against 65.7% over the last 60.
Latest results: a net profit of ₹1 cr for the quarter ended Mar 2026.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹62 cr |
| Net profit (last 12 months) | ₹3 cr |
| Sales growth, 3 years (yearly) | -34.6% |
| Profit growth, 3 years (yearly) | -3.9% |
At a glance
Promoters 29.3%, pledged 0.0%.
P/E 15.1, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 3.7%, ROCE 15.6%, operating margin 12.9%: how much profit it earns on the money it uses.
Debt/equity 0.99, Profit growth -3.9% and sales growth -34.6% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (3.7%).
- Profit fell 3.9% a year over 3 years.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q4 FY26)
VINEETLAB Q4 FY26 results (standalone figures, as filed on NSE).
Revenue was ₹18.89 crore.
Net profit was ₹1.22 crore.
Operating margin was 13.2%.
EPS was ₹0.43.
VINEETLAB के Q4 FY26 नतीजे (स्टैंडअलोन आंकड़े, NSE पर दाखिल)।
राजस्व: ₹18.89 करोड़।
शुद्ध मुनाफ़ा: ₹1.22 करोड़।
ऑपरेटिंग मार्जिन: 13.2%।
EPS: ₹0.43।
VINEETLABના Q4 FY26 પરિણામો (સ્ટેન્ડઅલોન આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹18.89 કરોડ.
ચોખ્ખો નફો: ₹1.22 કરોડ.
ઓપરેટિંગ માર્જિન: 13.2%.
EPS: ₹0.43.
Written from the filed numbers. Not a recommendation.
Smart-money activity
9/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 4/30: Delivery 72.6% over the last 20 sessions vs 72.9% in the 40 before (1x); shares delivered per day 0.97x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: Net −₹0.05 cr in bulk/block deals over 90 days (1 net buying day, 2 net selling days): more sold than bought.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Deal ● Results ● Rights
- 16 Oct 26Deal Bulk deal: ARJUN AGGARWAL +1 sold ₹1.21 cr +0.3% next session
- 29 Sept 26Deal Bulk deal: MANGAL KESHAV CAPITAL LIMITED bought ₹2.94 cr (net +₹1.21 cr) +5.2% next session
- 1 Sept 26Deal Bulk deal: ANASUYA GORLA sold ₹0.43 cr (net −₹0.05 cr) -3.3% next session
- 26 Aug 26Results Q4 FY26 results: net profit ₹1.2 cr +0.8% next session
- 23 Dec 25Rights Rights issue 13:12 · premium ₹20 (ex-date) -8.7% next session
- 19 Dec 25Results Q2 FY26 results: net profit ₹0.4 cr +1.2% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (standalone)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Mar 2026 | ₹19 cr | ₹1 cr | — | 13.2% | 0.43 |
| Sept 2025 | ₹17 cr | ₹0 cr | — | 18.2% | 0.43 |
| Sept 2023 | ₹43 cr | ₹2 cr | — | 9.6% | 2.62 |
| Mar 2023 | ₹57 cr | ₹4 cr | — | 10.1% | 3.85 |
Shareholding trend
| Holder | Jun 2025 | Dec 2024 |
|---|---|---|
| Promoters | 29.26% | 35.85% |
| Foreign institutions (FII) | — | 0.00% |
| Domestic institutions (DII) | — | 0.00% |
| Mutual funds | — | 0.00% |
| Retail investors | 42.88% | 41.63% |
| Number of shareholders | 9,988 | 10,058 |
Common questions
What was Vineet Laboratories Ltd.'s latest quarterly profit?
Vineet Laboratories Ltd. reported a net profit of ₹1 cr for the quarter ended Mar 2026, on revenue of ₹19 cr.
How much do promoters hold in Vineet Laboratories Ltd.?
Promoters held 29.26% of Vineet Laboratories Ltd. at the end of Jun 2025, with 0.00% of promoter shares pledged.
Is Vineet Laboratories Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.99.
What is Vineet Laboratories Ltd.'s P/E ratio?
About 15.1, based on the last 12 months' earnings and a price of ₹37.92 (data 2026-10-31).
What is the 52-week high and low of Vineet Laboratories Ltd.?
The 52-week high is ₹43.5 and the 52-week low is ₹27.96.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Vineet Laboratories Ltd. | ₹37.92 | ₹71 cr | 15.1 | — | 3.7% | 15.6% | 0.99 | -4.4% |
| Standard Industries Limited | ₹16.31 | ₹105 cr | 1.7 | — | -16.6% | -12.1% | 0.03 | -13.5% |
| Lead Reclaim & Rubber Products Ltd. | ₹103.45 | ₹101 cr | 21.9 | 3.7 | 18.5% | 24.2% | 0.52 | +40.9% |
| Deep Polymers Ltd. | ₹39 | ₹96 cr | — | — | 6.9% | 6.6% | 0.29 | +10.0% |
| Alkali Metals Ltd. | ₹78.02 | ₹76 cr | 31.1 | 1.8 | 1.2% | 10.3% | 0.41 | -14.0% |
| Renol Polychem Limited | ₹59.5 | ₹72 cr | 5.6 | — | — | 17.4% | 0.16 | -20.9% |
Compare VINEETLAB with SIL in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open VINEETLAB in NSE Scanner →